Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 0.33
AMED's Cash-to-Debt is ranked higher than
52% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 0.32 vs. AMED: 0.33 )
Ranked among companies with meaningful Cash-to-Debt only.
AMED' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.35 Max: N/A
Current: 0.33
Equity-to-Asset 0.63
AMED's Equity-to-Asset is ranked higher than
73% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 0.46 vs. AMED: 0.63 )
Ranked among companies with meaningful Equity-to-Asset only.
AMED' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.23  Med: 0.6 Max: 1
Current: 0.63
-0.23
1
Interest Coverage 11.10
AMED's Interest Coverage is ranked higher than
62% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 7.01 vs. AMED: 11.10 )
Ranked among companies with meaningful Interest Coverage only.
AMED' s Interest Coverage Range Over the Past 10 Years
Min: 2.93  Med: 15.44 Max: 115.64
Current: 11.1
2.93
115.64
Piotroski F-Score: 7
Altman Z-Score: 5.99
Beneish M-Score: -2.41
WACC vs ROIC
14.32%
6.82%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % 3.99
AMED's Operating Margin % is ranked lower than
65% of the 218 Companies
in the Global Medical Care industry.

( Industry Median: 6.53 vs. AMED: 3.99 )
Ranked among companies with meaningful Operating Margin % only.
AMED' s Operating Margin % Range Over the Past 10 Years
Min: -33.08  Med: 3 Max: 15.25
Current: 3.99
-33.08
15.25
Net Margin % 2.59
AMED's Net Margin % is ranked lower than
61% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 4.07 vs. AMED: 2.59 )
Ranked among companies with meaningful Net Margin % only.
AMED' s Net Margin % Range Over the Past 10 Years
Min: -26.96  Med: 1.83 Max: 9.33
Current: 2.59
-26.96
9.33
ROE % 8.66
AMED's ROE % is ranked lower than
51% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 9.23 vs. AMED: 8.66 )
Ranked among companies with meaningful ROE % only.
AMED' s ROE % Range Over the Past 10 Years
Min: -54.77  Med: 5.95 Max: 20.95
Current: 8.66
-54.77
20.95
ROA % 5.24
AMED's ROA % is ranked higher than
60% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 3.61 vs. AMED: 5.24 )
Ranked among companies with meaningful ROA % only.
AMED' s ROA % Range Over the Past 10 Years
Min: -35.44  Med: 3.55 Max: 12.39
Current: 5.24
-35.44
12.39
ROC (Joel Greenblatt) % 146.73
AMED's ROC (Joel Greenblatt) % is ranked higher than
92% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 15.77 vs. AMED: 146.73 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
AMED' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -326.21  Med: 77.02 Max: 233.27
Current: 146.73
-326.21
233.27
3-Year Revenue Growth Rate 2.10
AMED's 3-Year Revenue Growth Rate is ranked lower than
74% of the 182 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. AMED: 2.10 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
AMED' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -23  Med: 6.7 Max: 35.1
Current: 2.1
-23
35.1
GuruFocus has detected 4 Warning Signs with Amedisys Inc $AMED.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» AMED's 10-Y Financials

Financials (Next Earnings Date: 2017-06-09 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

AMED Guru Trades in Q1 2016

RS Investment Management 802,082 sh (New)
Jim Simons 630,901 sh (+81.14%)
Paul Tudor Jones Sold Out
Steven Cohen 91,900 sh (-5.55%)
Joel Greenblatt 229,703 sh (-33.59%)
» More
Q2 2016

AMED Guru Trades in Q2 2016

Pioneer Investments 52,747 sh (New)
Jim Simons 633,001 sh (+0.33%)
Steven Cohen Sold Out
RS Investment Management 801,563 sh (-0.06%)
Joel Greenblatt 51,565 sh (-77.55%)
» More
Q3 2016

AMED Guru Trades in Q3 2016

Pioneer Investments Sold Out
Jim Simons 369,401 sh (-41.64%)
Joel Greenblatt 5,938 sh (-88.48%)
» More
Q4 2016

AMED Guru Trades in Q4 2016

Joel Greenblatt Sold Out
Jim Simons 262,300 sh (-28.99%)
» More
» Details

Insider Trades

Latest Guru Trades with AMED

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621610    SIC: 8082
Compare:NYSE:SEM, OTCPK:RHKJF, NYSE:THC, NYSE:AMN, NAS:SCAI, NAS:TVTY, NAS:PAHC, NYSE:CYH, NAS:SGRY, NAS:LHCG, NAS:LPNT, NYSE:USPH, OTCPK:LTGHY, NAS:AFAM, NAS:PRSC, OTCPK:RLGHF, OTCPK:MFCSF, NYSE:CHE, NAS:ADUS, NAS:BIOS » details
Traded in other countries:ADY.Germany,
Amedisys Inc is a provider of low-cost home health services to the chronic, co-morbid, aging American population. The Company's operations involve servicing patients through its two reportable business segments: home health and hospice.

Amedisys Inc was incorporated in Louisiana in 1982. Its operations were transferred to a Delaware corporation, which was incorporated in 1994; and became a publicly traded company in August of that year. The Company is a provider of low-cost home health services to the chronic, co-morbid, aging American population. The operations involve servicing patients through its three reportable business segments: home health, hospice and personal care. The home health segment delivers services in the homes of individuals who may be recovering from an illness, injury or surgery. Its hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. Personal care segment provides patients assistance with the essential activities of daily living. Individuals with a terminal illness such as heart disease, pulmonary disease, dementia, Alzheimers, HIV/AIDS or cancer may be eligible for hospice care. The Company operates 41 home health care centers and five hospice care centers with care centers servicing the same markets, sold 19 home health care centers and one hospice care center and closed 10 home health care centers. The Company's operations are regulated by Federal, state and local authorities.

Ratios

vs
industry
vs
history
PE Ratio 46.44
AMED's PE Ratio is ranked lower than
75% of the 279 Companies
in the Global Medical Care industry.

( Industry Median: 28.41 vs. AMED: 46.44 )
Ranked among companies with meaningful PE Ratio only.
AMED' s PE Ratio Range Over the Past 10 Years
Min: 4.65  Med: 17.06 Max: 79.39
Current: 46.44
4.65
79.39
Forward PE Ratio 25.25
AMED's Forward PE Ratio is ranked lower than
72% of the 98 Companies
in the Global Medical Care industry.

( Industry Median: 19.01 vs. AMED: 25.25 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 46.44
AMED's PE Ratio without NRI is ranked lower than
76% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 27.34 vs. AMED: 46.44 )
Ranked among companies with meaningful PE Ratio without NRI only.
AMED' s PE Ratio without NRI Range Over the Past 10 Years
Min: 4.65  Med: 17.08 Max: 77.36
Current: 46.44
4.65
77.36
PB Ratio 3.77
AMED's PB Ratio is ranked lower than
65% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 2.42 vs. AMED: 3.77 )
Ranked among companies with meaningful PB Ratio only.
AMED' s PB Ratio Range Over the Past 10 Years
Min: 0.5  Med: 2.08 Max: 4.2
Current: 3.77
0.5
4.2
PS Ratio 1.20
AMED's PS Ratio is ranked higher than
61% of the 270 Companies
in the Global Medical Care industry.

( Industry Median: 1.55 vs. AMED: 1.20 )
Ranked among companies with meaningful PS Ratio only.
AMED' s PS Ratio Range Over the Past 10 Years
Min: 0.19  Med: 0.79 Max: 1.9
Current: 1.2
0.19
1.9
Price-to-Free-Cash-Flow 37.35
AMED's Price-to-Free-Cash-Flow is ranked lower than
69% of the 134 Companies
in the Global Medical Care industry.

( Industry Median: 26.27 vs. AMED: 37.35 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
AMED' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 2.95  Med: 11.3 Max: 87.98
Current: 37.35
2.95
87.98
Price-to-Operating-Cash-Flow 27.91
AMED's Price-to-Operating-Cash-Flow is ranked lower than
83% of the 191 Companies
in the Global Medical Care industry.

( Industry Median: 14.39 vs. AMED: 27.91 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
AMED' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.02  Med: 6.57 Max: 30.78
Current: 27.91
2.02
30.78
EV-to-EBIT 26.91
AMED's EV-to-EBIT is ranked lower than
68% of the 290 Companies
in the Global Medical Care industry.

( Industry Median: 19.26 vs. AMED: 26.91 )
Ranked among companies with meaningful EV-to-EBIT only.
AMED' s EV-to-EBIT Range Over the Past 10 Years
Min: -178.9  Med: 7.5 Max: 2214.4
Current: 26.91
-178.9
2214.4
EV-to-EBITDA 20.79
AMED's EV-to-EBITDA is ranked lower than
73% of the 303 Companies
in the Global Medical Care industry.

( Industry Median: 14.06 vs. AMED: 20.79 )
Ranked among companies with meaningful EV-to-EBITDA only.
AMED' s EV-to-EBITDA Range Over the Past 10 Years
Min: -7.4  Med: 7 Max: 65.5
Current: 20.79
-7.4
65.5
Current Ratio 1.19
AMED's Current Ratio is ranked lower than
55% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 1.28 vs. AMED: 1.19 )
Ranked among companies with meaningful Current Ratio only.
AMED' s Current Ratio Range Over the Past 10 Years
Min: 0.42  Med: 1 Max: 2.83
Current: 1.19
0.42
2.83
Quick Ratio 1.19
AMED's Quick Ratio is ranked higher than
52% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. AMED: 1.19 )
Ranked among companies with meaningful Quick Ratio only.
AMED' s Quick Ratio Range Over the Past 10 Years
Min: 0.4  Med: 1 Max: 2.75
Current: 1.19
0.4
2.75
Days Sales Outstanding 42.17
AMED's Days Sales Outstanding is ranked higher than
53% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 44.02 vs. AMED: 42.17 )
Ranked among companies with meaningful Days Sales Outstanding only.
AMED' s Days Sales Outstanding Range Over the Past 10 Years
Min: 30.1  Med: 37.17 Max: 54.01
Current: 42.17
30.1
54.01
Days Payable 13.30
AMED's Days Payable is ranked lower than
81% of the 143 Companies
in the Global Medical Care industry.

( Industry Median: 40.41 vs. AMED: 13.30 )
Ranked among companies with meaningful Days Payable only.
AMED' s Days Payable Range Over the Past 10 Years
Min: 8.33  Med: 12.25 Max: 16.02
Current: 13.3
8.33
16.02

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.10
AMED's 3-Year Average Share Buyback Ratio is ranked higher than
65% of the 129 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. AMED: -1.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
AMED' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -42.8  Med: -8.4 Max: -1.1
Current: -1.1
-42.8
-1.1

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 13.89
AMED's Price-to-Tangible-Book is ranked lower than
87% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 4.00 vs. AMED: 13.89 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
AMED' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.2  Med: 6.13 Max: 29.62
Current: 13.89
0.2
29.62
Price-to-Intrinsic-Value-Projected-FCF 2.35
AMED's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
58% of the 137 Companies
in the Global Medical Care industry.

( Industry Median: 2.07 vs. AMED: 2.35 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
AMED' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.16  Med: 1.25 Max: 2.73
Current: 2.35
0.16
2.73
Price-to-Median-PS-Value 1.53
AMED's Price-to-Median-PS-Value is ranked lower than
75% of the 246 Companies
in the Global Medical Care industry.

( Industry Median: 1.09 vs. AMED: 1.53 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
AMED' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.21  Med: 0.88 Max: 2.35
Current: 1.53
0.21
2.35
Price-to-Peter-Lynch-Fair-Value 0.63
AMED's Price-to-Peter-Lynch-Fair-Value is ranked lower than
99.99% of the 80 Companies
in the Global Medical Care industry.

( Industry Median: 2.23 vs. AMED: 0.63 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
AMED' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0  Med: 0.75 Max: 3.24
Current: 0.63
0
3.24
Price-to-Graham-Number 5.36
AMED's Price-to-Graham-Number is ranked lower than
92% of the 165 Companies
in the Global Medical Care industry.

( Industry Median: 2.50 vs. AMED: 5.36 )
Ranked among companies with meaningful Price-to-Graham-Number only.
AMED' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 2.28  Med: 3.19 Max: 5.38
Current: 5.36
2.28
5.38
Earnings Yield (Greenblatt) % 3.70
AMED's Earnings Yield (Greenblatt) % is ranked lower than
57% of the 332 Companies
in the Global Medical Care industry.

( Industry Median: 4.31 vs. AMED: 3.70 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
AMED' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.1  Med: 9.1 Max: 32.8
Current: 3.7
0.1
32.8
Forward Rate of Return (Yacktman) % 34.70
AMED's Forward Rate of Return (Yacktman) % is ranked higher than
91% of the 119 Companies
in the Global Medical Care industry.

( Industry Median: 10.14 vs. AMED: 34.70 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
AMED' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 7  Med: 40.9 Max: 109.3
Current: 34.7
7
109.3

More Statistics

Revenue (TTM) (Mil) $1,437
EPS (TTM) $ 1.11
Beta1.53
Short Percentage of Float18.44%
52-Week Range $34.58 - 55.16
Shares Outstanding (Mil)33.61

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 1,518 1,593
EPS ($) 2.04 2.36
EPS without NRI ($) 2.04 2.36
EPS Growth Rate
(Future 3Y To 5Y Estimate)
15.00%
Dividends per Share ($)
» More Articles for AMED

Headlines

Articles On GuruFocus.com
“Powerball” Ideas - Home Healthcare Companies: AFAM, GTIV, LHCG, AMED Jan 05 2012 
AMED: Investment Opportunity When the Price Hits an 8-Year Low Dec 27 2011 
Almost Family: The Magic Formula Stock is getting cheaper and cheaper Dec 11 2011 
Magic Formula Stock: Amedisys (AMED) Aug 05 2011 
Home Healthcare: Heavily Shorted long Opportunity May 30 2011 
Amedisys Inc (AMED) CFO Dale E Redman buys 1,000 Shares Aug 25 2010 
Amedisys Inc Reports Operating Results (10-Q) Aug 09 2010 
Amedisys Inc Reports Operating Results (10-Q) Apr 27 2010 
Amedisys Inc (AMED) Chairman of the Board William F Borne sells 25,000 Shares Feb 24 2010 
Amedisys Inc (AMED) Chairman of the Board William F Borne sells 12,500 Shares Dec 29 2009 

More From Other Websites
AMEDISYS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Mar 21 2017
Amedisys to Present at the 27th Annual Oppenheimer Healthcare Conference Mar 13 2017
Amedisys Stock Up on Solid Earnings, Reimbursement Woes Stay Mar 03 2017
Amedisys, Inc. :AMED-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017 Mar 02 2017
Tenet Healthcare (THC) to Divest Operations to Amedisys Mar 02 2017
Amedisys (AMED) Catches Eye: Stock Gains 6.2% in Session Mar 02 2017
Amedisys Buys 6 Home Health, Hospice Care Centers from Tenet Mar 02 2017
AMEDISYS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Mar 01 2017
Amedisys Announces Definitive Agreement to Acquire Six Home Health and Hospice Care Centers from... Mar 01 2017
AMEDISYS INC Files SEC form 10-K, Annual Report Mar 01 2017
Amedisys (AMED) Earnings Top Q4 Estimates, Revenues Lag Mar 01 2017
7:10 pm Amedisys beats by $0.05, reports revs in-line Feb 28 2017
Amedisys tops 4Q profit forecasts Feb 28 2017
Amedisys tops 4Q profit forecasts Feb 28 2017
Amedisys Reports Fourth Quarter and Year End 2016 Financial Results Feb 28 2017
AMEDISYS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Feb 28 2017
Q4 2016 Amedisys Inc Earnings Release - After Market Close Feb 28 2017
Amedisys Announces Fourth Quarter Earnings Release and Conference Call Date Feb 20 2017
AMEDISYS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Feb 02 2017
Amedisys Closes On Acquisition of Home Staff, LLC Feb 02 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)